Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic: A population-based, nation-wide study

Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt

Standard

Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic : A population-based, nation-wide study. / Faitová, Tereza; Brieghel, Christian; Eriksson, Frank; Niemann, Carsten U.

I: HemaSphere, Bind 8, Nr. 3, e57, 2024.

Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt

Harvard

Faitová, T, Brieghel, C, Eriksson, F & Niemann, CU 2024, 'Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic: A population-based, nation-wide study', HemaSphere, bind 8, nr. 3, e57. https://doi.org/10.1002/hem3.57

APA

Faitová, T., Brieghel, C., Eriksson, F., & Niemann, C. U. (2024). Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic: A population-based, nation-wide study. HemaSphere, 8(3), [e57]. https://doi.org/10.1002/hem3.57

Vancouver

Faitová T, Brieghel C, Eriksson F, Niemann CU. Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic: A population-based, nation-wide study. HemaSphere. 2024;8(3). e57. https://doi.org/10.1002/hem3.57

Author

Faitová, Tereza ; Brieghel, Christian ; Eriksson, Frank ; Niemann, Carsten U. / Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic : A population-based, nation-wide study. I: HemaSphere. 2024 ; Bind 8, Nr. 3.

Bibtex

@article{15c18fbaa500498d852a48e5abf94fe7,
title = "Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic: A population-based, nation-wide study",
abstract = "Patients with B-cell-derived malignancies are at increased risk of severe coronavirus disease 2019 (COVID-19) due to the inherent immune dysfunction and/or treatment. To protect patients in general and patients with B-cell-derived malignancies in particular from COVID-19, management of these patients was changed toward virtual consultations during the pandemic. Whether the COVID-19 pandemic itself and/or changes in management have led to excess mortality among hematological patients during the COVID-19 pandemic in Denmark has not yet been investigated.",
author = "Tereza Faitov{\'a} and Christian Brieghel and Frank Eriksson and Niemann, {Carsten U}",
year = "2024",
doi = "10.1002/hem3.57",
language = "English",
volume = "8",
journal = "HemaSphere",
issn = "2572-9241",
publisher = "Lippincott, Williams & Wilkins",
number = "3",

}

RIS

TY - JOUR

T1 - Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic

T2 - A population-based, nation-wide study

AU - Faitová, Tereza

AU - Brieghel, Christian

AU - Eriksson, Frank

AU - Niemann, Carsten U

PY - 2024

Y1 - 2024

N2 - Patients with B-cell-derived malignancies are at increased risk of severe coronavirus disease 2019 (COVID-19) due to the inherent immune dysfunction and/or treatment. To protect patients in general and patients with B-cell-derived malignancies in particular from COVID-19, management of these patients was changed toward virtual consultations during the pandemic. Whether the COVID-19 pandemic itself and/or changes in management have led to excess mortality among hematological patients during the COVID-19 pandemic in Denmark has not yet been investigated.

AB - Patients with B-cell-derived malignancies are at increased risk of severe coronavirus disease 2019 (COVID-19) due to the inherent immune dysfunction and/or treatment. To protect patients in general and patients with B-cell-derived malignancies in particular from COVID-19, management of these patients was changed toward virtual consultations during the pandemic. Whether the COVID-19 pandemic itself and/or changes in management have led to excess mortality among hematological patients during the COVID-19 pandemic in Denmark has not yet been investigated.

U2 - 10.1002/hem3.57

DO - 10.1002/hem3.57

M3 - Letter

C2 - 38505245

VL - 8

JO - HemaSphere

JF - HemaSphere

SN - 2572-9241

IS - 3

M1 - e57

ER -

ID: 385889080